July - December 2016 | Vol 1 | Issue 1 | Page : 6-9
Thiago Mamôru Sakae1
1Anesthesiologist, Ph.D. in Medical Sciences, Professor of Epidemiology, Federal University of Santa Catarina, Professor of Epidemiology, UNISUL, University of Southern Santa Catarina.
Hemophilia is a hemorrhagic trend affects mostly males (X-related recessive disease). In 85% of cases it is caused by factor VIII deficiency, being called hemophilia A or classic hemophilia. In approximately 15% of cases there is factor IX deficiency (hemophilia B). The objective of this report was to describe the case of a patient with Hemophilia B underwent a femur fracture surgery. Male patient-18 years old, 81.7 kg, 183 cm, carrying hemophilia B, victim of a motorcycle traffic accident, was admitted in emergency room with Glasgow 15, excoriations in arms and thorax, and a femur fracture. He was first subjected to external fixation and posteriorly underwent surgery to correct a distal femur fracture. Hemophiliac patients' administration has made strides. Hemophilia ought not to be a contraindication for an obtrusive strategy; be that as it may, various conditions are required to give effective surgery and an uncomplicated and safe postoperative course.
Keywords: Femur Fracture, Factor IX, Hemophilia B.
- Nazeef M, Sheehan JP. New developments in the management of moderate-to-severe hemophilia B. J Blood Med. 2016:1;7:27-38.
- Boayue KB, Bell BA. Characteristics and management of bleeding in hemophilia and von Willebrand disease, Int J Pediat Hem Onc, 1994;1:449-461.
- Flores RPG, Bagatini A, Santos ATL, Gomes CR, Fernandes MS, Molon RP. Hemophilia and Anesthesia. Rev Bras Anestesiol 2004; 54(6): 865 – 871.
- Acharya SS. Exploration of the pathogenesis of haemophilic joint arthropathy: understanding implications for optimal clinical management. Br J Haematol. 2012;156(1):13–23.
- White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85(3):560.
- Lison S, Spannagl M. Perioperative management of patients with hemophilia. Anaesthesist. 2014;63(1):6-15.
- Li Y, Weng XS, Lin J, Jin J, Qian WW, Zhang BZ, Gao P, Zhai JL. Perioperative Period of a Hemophilia-related Osteoarthropathy Therapeutic Regimen and Analysis of Complications. Orthop Surg. 2016;8(1):60-7.
- Ferreira AA, Cangiani LM, Vanetti LFA. Anestesia e o paciente hemofílico. Rev Bras Anestesiol, 1977;27:467-474.
- Makino S, Nomura Y, Kabara S, Takatsuji S, Kagawa T. Anesthetic management of a patient with hemophilia B during scoliosis surgery. Masui. 2013;62(10):1241-4.
- Módolo NSP, Azevedo VLF, Santos PSS, Rosa ML, Corvino DR, Alves LJSC. Anesthetic Strategy for Cesarean Section in a Patient with Factor XI Deficiency. Case Report. Rev Bras Anestesiol. 2010; 60(2): 176-180.
- Shetty S, Ghosh K. Why should hemophilia B be milder than hemophilia A? Haematologica 2016;101: e213.
- DiMichele D, Neufeld EJ. Hemophilia. A new approach to an old disease. Hematol Oncol Clin North Am, 1998;12:1315-1344.
- Caicedo MV, Raffan F, Duarte M. Manejo perioperatorio del paciente hemofílico. Revista Mexicana de Anestesiología. 2009:32(3);177-185.
- Guidelines for the Management of Hemophilia, World Federation of Hemophilia 2005. www.wfh.org/2/docs/Publications/Diagnosis_and_Treatment/Gudelines_Mng_Hemophilia.pdf
- Giangrande P. The Future of Hemophilia Treatment: Longer-Acting Factor Concentrates versus Gene Therapy. Semin Thromb Hemost. 2016:5;26-31.
- Manco-Johnson MJ, Abshire TC, Shapiro AD. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535–544.
- Kapadia BH, Boylan MR, Elmallah RK, Krebs VE, Paulino CB, Mont MA. Does Hemophilia Increase the Risk of Postoperative Blood Transfusion After Lower Extremity Total Joint Arthroplasty? J Arthroplasty. 2016:21;72-3.